M. Beckett

Immunology · 2009–2014

A researcher in the Science corpus: 3 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom M. Beckett trusts

Their strongest outbound trust, strongest first, inferred from their citations.

  1. D. Pardoll (in Immunology)
  2. Antoni Ribas (in Oncology)

Papers from M. Beckett's perspective

Ordered by how strongly the researchers M. Beckett trusts endorse each paper. Same corpus, a different order for every researcher.

  1. The blockade of immune checkpoints in cancer immunotherapy (Nature Reviews. Cancer)
  2. Restoring function in exhausted CD8 T cells during chronic viral infection (Nature)
  3. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells (Journal of Experimental Medicine)
  4. The Programmed Death-1 (PD-1) Pathway Regulates Autoimmune Diabetes in Nonobese Diabetic (NOD) Mice (Journal of Experimental Medicine)
  5. Tumor immunotherapy directed at PD-1. (New England Journal of Medicine)
  6. Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer (New England Journal of Medicine)
  7. Cyclic GMP-AMP Containing Mixed Phosphodiester Linkages Is An Endogenous High Affinity Ligand for STING (Molecules and Cells)
  8. Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity (Journal of Experimental Medicine)
  9. PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors (Proceedings of the National Academy of Sciences of the United States of America)
  10. Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice. (Journal of Clinical Investigation)

Their papers